Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1319 |
|
| Actual shortage: | 60 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1223 (93%) | |
Discontinuation Reports |
287 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 283 (99%) | |
| Reversed: | 2 (1%) | |
Late reports |
210 (13%) |
|
Overdue reports |
27 (44%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Resolved | 2018-03-23 | 2020-06-09 | 43848 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Resolved | 2017-06-23 | 2020-06-09 | 13688 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Resolved | 2017-03-24 | 2020-06-09 | 4161 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Resolved | 2017-12-07 | 2020-06-09 | 32028 |
| ASAPHEN | 80MG | TABLET (CHEWABLE) | Resolved | 2024-12-04 | 2025-02-18 | 244817 |
| ASAPHEN | 80MG | TABLET (CHEWABLE) | Resolved | 2017-04-20 | 2017-10-26 | 7328 |
| ASAPHEN | 80MG | TABLET (CHEWABLE) | Resolved | 2017-05-25 | 2017-09-19 | 11291 |
| ASAPHEN | 80MG | TABLET (CHEWABLE) | Resolved | 2019-11-15 | 2020-03-10 | 98787 |
| ASAPHEN E.C. 80 MG | 80MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-06-23 | 2018-05-05 | 13691 |
| ASAPHEN E.C. 80 MG | 80MG | TABLET (DELAYED-RELEASE) | Avoided shortage | 2017-05-02 | 2017-10-12 | 8528 |
| ASAPHEN E.C. 80 MG | 80MG | TABLET (DELAYED-RELEASE) | Avoided shortage | 2017-06-16 | 2017-10-12 | 13093 |
| ASAPHEN E.C. 80 MG | 80MG | TABLET (DELAYED-RELEASE) | Avoided shortage | 2018-03-07 | 2018-05-04 | 42092 |
| ASAPHEN E.C. 80 MG | 80MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-03-28 | 2019-05-09 | 79783 |
| ATORVASTATIN | 20MG | TABLET | Resolved | 2019-11-15 | 2020-07-23 | 98790 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Resolved | 2017-03-24 | 2017-10-11 | 4175 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Resolved | 2017-03-13 | 2020-04-02 | 1794 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Resolved | 2017-04-20 | 2020-06-09 | 7341 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Resolved | 2017-04-07 | 2017-10-11 | 6019 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Resolved | 2017-04-04 | 2017-10-11 | 5460 |
| CHARCODOTE-AQUEOUS SUS 200MG/ML | 200MG | SUSPENSION | Resolved | 2017-03-13 | 2020-04-02 | 1805 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMSC-METFORMIN | 850MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248801 |
| SOFLAX SYRUP 4MG/ML | 20MG | SYRUP | Discontinued | 2021-04-23 | 2021-04-23 | 138006 |
| TELMISARTAN | 40MG | TABLET | Discontinued | 2017-12-15 | 2018-02-02 | 33129 |
| TELMISARTAN | 80MG | TABLET | Discontinued | 2018-07-19 | 2021-10-27 | 56080 |
| TELMISARTAN-HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25720 |
| TELMISARTAN-HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25724 |
| PMS-DIGOXIN | 0.250MG | TABLET | Discontinued | 2020-02-05 | 2020-02-05 | 105265 |